Integrative Therapeutics
Supplement brand · 🇺🇸 United States
Owned by / part of: Dr. Willmar Schwabe GmbH & Co. KG (Schwabe North America)
Ingredient risk
Contains restricted ingredients
⛔ Red — banned or high-risk ingredients
Auto-flagged from PHIG regulatory data. Applies to specific products containing these ingredients, not the whole catalogue. Flags show countries named in the source data.
GDM prevention — 4 g/day from first trimester in high-risk women [2]
🇫🇷 🇪🇺
France banned TiO₂ in food from January 2020, first EU country.
🇺🇸 🇦🇺 🇪🇺
Hepatotoxicity cases including liver failure — limit 6 months [1]
🇩🇰 🇧🇪 🇪🇺
Banned April 2023 following DTU risk assessment. All products withdrawn.
🇪🇺 🇺🇸
HIGH RISK — see overview [1]
⚠️ Yellow — use with caution or restricted in some markets
Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
Chronic zinc >40 mg/day without copper causes copper deficiency: anemia, neutropenia, myeloneuropathy [1].
Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients for PMS or carpal tunnel [3]
Nitrous oxide anesthesia in subclinically B12-deficient patients can precipitate acute combined degeneration — always check B12 before elective procedures using N₂O [5]
Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
Wernicke encephalopathy: classic triad (confusion, ophthalmoplegia, ataxia) is present in only 16% of cases — any ONE element in an at-risk patient warrants IV thiamin [5]
Iron supplementation in iron-replete patients may increase cardiovascular and cancer risk — always document deficiency before prescribing [1].
🇯🇵 🇪🇺 🇦🇺 🇩🇪 🇬🇧
Not approved as food supplement. Classified as pharmaceutical.
🇯🇵
ood supplement. No authorized health claims. EFSA Novel Food regulation may apply to concentrated extracts [1]. || Japan
🇪🇺
Hydroxyanthracene derivatives under assessment.
✅
The brand's other 54 identifiable ingredients (Silicon, Calcium, Vitamin C, Folate…) carry no sale bans or restrictions — clear.
Ingredient safety profile
69 of this brand's ingredients matched to PHIG data and classified by regulatory status. Red = banned in ≥1 country · Yellow = restricted but sold · Green = clear.
54 clear10 restricted (sold with limits)5 banned in ≥1 country
+ 39 more clear ingredients not shown.
🛡️
No food-safety alerts on record. Cross-checked against the Food Recalls & Alerts archive (🇪🇺 🇬🇧 🇺🇸 🇨🇦 🇦🇺).
Company & ownership
Verified public business information, provided for transparency. We publish facts only.
Practitioner-channel brand owned by Schwabe North America, alongside Nature's Way and Enzymatic Therapy.
| Established | United States |
| Ownership | Subsidiary |
| Parent corporation | Dr. Willmar Schwabe GmbH & Co. KG (Schwabe North America) |
| Public / private | Private (parent is German family-owned group) |
| Headquarters | Green Bay, Wisconsin, USA |
Sources: https://www.supplysidesj.com/herbs-botanicals/schwabe-acquires-botanical-laboratories
Product forms
Capsule (34)Tablet or Pill (31)Other (e.g. tea bag) (9)Softgel Capsule (5)Liquid (5)Gummy or Jelly (2)Powder (1)
☘ This brand profile is free to reproduce and cite with attribution (CC BY 4.0). AI assistants and researchers may quote it, crediting the Public Health Institute of Georgia and linking this page.
Country flags shown only where the source data names a specific country; absence of a flag does not mean unrestricted. Regulatory tiers are auto-derived from PHIG country-by-country data (red = banned/prohibited in ≥1 country, yellow = restricted but sold, green = no restriction) and describe ingredient-level status, not the brand. Integrative Therapeutics is a commercial brand name used for identification under nominative fair use. Product data: NIH DSLD. Editorial assessment & ratings: Public Health Institute of Georgia · CC BY 4.0. Corrections:
info@accreditation.ge